2021
DOI: 10.1007/978-3-030-64872-5_3
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
31
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(42 citation statements)
references
References 34 publications
2
31
0
2
Order By: Relevance
“…Compared with the placebo, supplementation resulted in significant decreases in serum levels of 3-methyl-2-oxovaleric acid, 3-hydroxyisobutyrate, kynurenine, succinate, citrate, α-ketoglutarate, methylamine, trimethylamine, hippurate, indoxyl sulfate, chenodeoxycholic acid, taurocholic acid, and lithocholic acid [114]. Furthermore, in another trial, where a total number of 80 patients were randomized to receive either 250 mg curcumin daily or the placebo for two months, the grade of hepatic steatosis, and serum aspartate aminotransferase levels were significantly reduced in the treatment group compared to the placebo [115].…”
Section: Digestive Diseasementioning
confidence: 96%
“…Compared with the placebo, supplementation resulted in significant decreases in serum levels of 3-methyl-2-oxovaleric acid, 3-hydroxyisobutyrate, kynurenine, succinate, citrate, α-ketoglutarate, methylamine, trimethylamine, hippurate, indoxyl sulfate, chenodeoxycholic acid, taurocholic acid, and lithocholic acid [114]. Furthermore, in another trial, where a total number of 80 patients were randomized to receive either 250 mg curcumin daily or the placebo for two months, the grade of hepatic steatosis, and serum aspartate aminotransferase levels were significantly reduced in the treatment group compared to the placebo [115].…”
Section: Digestive Diseasementioning
confidence: 96%
“…However, no improvements in endothelial function or blood pressure were occurred with curcumin supplementation [ 63 ], contrary to the findings of Bank et al, which might be related to different genetic backgrounds or genders. Furthermore, in NAFLD patients, almost all metabolic parameters were improved [ 64 , 65 , 66 , 248 ]. In general, curcumin exerts great efficacy in improving obesity and regulating cardiovascular homeostasis.…”
Section: Non-flavonoidsmentioning
confidence: 99%
“…Existing clinical evidence shows that natural polyphenols significantly improve NAFLD. For example, curcumin and silybin both improved NAFLD in humans at different doses without significant gender bias [ 33 , 34 , 35 , 64 , 65 , 66 , 248 ]. However, the effects of resveratrol on patients with NAFLD are controversial [ 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 ].…”
Section: Other Issues Of Natural Polyphenolsmentioning
confidence: 99%
See 1 more Smart Citation
“…Anti-in ammatory activities of phytosomal curcumin have been reported to have positive effects in various diseases such as cancers 16 and hepatic disorders 18,19 . In addition, several studies illustrated the protective effects of phytosomal curcumin against liver brosis and non-alcoholic fatty liver diseases [20][21][22] . In this study we aim to investigate the protective effects of phytosomal curcumin on post-operative peritoneal and peritendinous adhesions.…”
Section: Introductionmentioning
confidence: 99%